Use of intrahepatic chemotherapy to treat advanced pediatric hepatic malignancies

Journal of Pediatric Gastroenterology and Nutrition

Volumn 30, Issue 2, 2000, Pages 137-144

  Gerber, David A ^a   Arcement, Chris ^b   Carr, Brian ^b   Towbin, Rich ^b   Mazariegos, George ^b   Reyes, Jorge ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Hepatoblastoma; Hepatocellular carcinoma; Intrahepatic chemoembolization; Transplantation

Indexed keywords

CISPLATIN; DOXORUBICIN;

ADOLESCENT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL PROTOCOL; HEPATOBLASTOMA; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ALPHA-FETOPROTEINS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; CISPLATIN; COHORT STUDIES; DOXORUBICIN; HEPATIC ARTERY; HEPATOBLASTOMA; HUMANS; INFANT; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; LIVER TRANSPLANTATION; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0034081959     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200002000-00009     Document Type: Article

References (40)

1. Wheatley J, LaQuaglia M. Management of hepatic epithelial malignancy in childhood and adolescence. Semin Surg Oncol 1993; 9:532-40.
2. Finegold M. Tumors of the liver. Semin Liver Dis 1994;14:270-81.
3. Vos A. Paediatric surgical oncology. Eur J Surg Oncol 1995;21: 101-5.
4. Ni Y, Chang M, Hsu H, et al. Hepatocellular carcinoma in childhood: Clinical manifestations and prognosis. Cancer 1991;68: 1737-41.
5. Giacomantonio M, Ein S, Mancer K, Stephens C. Thirty years of experience with pediatric primary malignant liver tumors. J Pediatr Surg 1984;19:523-6.
6. Gururangan S, O'Meara A, Macmahon C, et al. Primary hepatic tumors in children: A 26-year review. J Surg Oncol 1992;50:30-6.
7. Von Schweinitz D, Burger D, Mildenberger H. Is laparotomy the first step in treatment of childhood liver tumors? The experience from the German Cooperative Pediatric Liver Tumor Study HB-89. Eur J Pediatr Surg 1994;4:82-6.
8. Ortega J, Krailo M, Haas J, et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: A report from the Children's Cancer Study Group. J Clin Oncol 1991;9:2167-76.
9. Reynolds M. Conversion of unresectable to resectable hepatoblastoma and long-term follow-up study. World J Surg 1995;19:814-6.
10. Ninane J, Perilongo G, Stalens J, Guglielmi M, Otte J, Mancini A. Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: A SIOP pilot study. Med Pediatr Oncol 1991;19:199-203.
11. Stringer M, Hennayake S, Howard E, et al. Improved outcome for children with hepatoblastoma. Br J Surg 1995;82:386-91.
12. King D, Ortega J, Campbell J, et al. The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy. J Pediatr Surg 1991;26:1074-81.
13. Pazdur R, Bready B, Cangir A. Pediatric hepatic tumors: Clinical trials conducted in the United States. J Surg Oncol Suppl 1993;3: 127-30.
14. Evans A, Land V, Newton W, Randolph J, Sather H, Tefft M. Combination chemotherapy (vincristine, adriamycin, cyclophosphadmide and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 1982;50:821-6.
15. Newman K. Malignant liver tumors of children. Semin Pediatr Surg 1992;1:145-51.
16. American Joint Committee on Cancer. Manual for staging of cancer. 3rd ed. Philadelphia: JB Lippincott, 1987:87-92.
17. Morino M, Miglietta C, Grosso M, De Giuli M, Bismuth H. Preoperative chemoembolization for hepatocellular carcinoma. J Surg Oncol Suppl 1993;3:91-3.
18. Soulen M. Chemoembolization of hepatic malignancies. Oncology 1994;8:77-84.
19. American Joint Committee on Cancer. Manual for staging cancer. 5th ed. Philadelphia: Lippincott-Raven, 1997:97-101.
20. Douglass E, Reynolds M, Finegold M, Cantor A, Glicksman A. Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: A Pediatric Oncology Group Study. J Clin Oncol 1993;11:96-9.
21. Wheatley JM, LaQuaglia MP. Management of hepatic epithelial malignancy in childhood and adolescence. Semin Surg Oncol 1993;9:532-40.
22. Douglass E, Ortega J, Feusner J. Hepatocellular carcinoma in children and adolescents: Results from the Pediatric Intergroup Hepatoma Study (CCG 8881/POG 8945). Proc Am Soc Clin Oncol 1994;13:416.
23. 2) for hepatocellular carcinoma: Clinical and pharmacokinetic results. Cancer Treat Rep 1984;68:487-91.
24. Vexler A, Mou X, Gabizon A, Gordetsky R. Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies. Int J Cancer 1995;60:611-5.
25. Melia W, Johnson P, Williams R. Induction of remission in hepatocellular carcinoma: A comparison of VP16 with adriamycin. Cancer 1983;51:206-10.
26. Otte JB, Aronson D, Vraux H, et al. Preoperative chemotherapy, major liver resection, and transplantation for primary malignancies in children. Transplant Proc 1996;28:2393-4.
27. Broughan T, Esquivel C, Vogt D, Griffin G, Morris D. Pretransplant chemotherapy in pediatric hepatocellular carcinoma. J Pediatr Surg 1994;29:1319-22.
28. Nakagawa N, Cornelius A, Kao S, Nakajima Y, Nakada K. Transcatheter oily chemoembolization for unresectable malignant liver tumors in children. J Vasc Interv Radiol 1993;4:353-8.
29. Bronowicki JP, Vetter D, Dumas F, et al. Transcatheter oily chemoembolization for hepatocellular carcinoma. Cancer 1994;74: 16-24.
30. Ngan H, Lai CL, Fan ST, Lai E, Yuen WK, Tso WK. Transcatheter arterial chemoembolization in inoperable hepatocellular carcinoma: Four-year follow-up. J Vasc Interv Radiol 1996;7:419-25.
31. Hatanaka Y, Yamashita Y, Takahaski Ml, et al. Unresectable hepatocellular carcinoma: Analysis of prognostic factors in transcatheter management. Radiology 1995;195:747-52.
32. Jaeger H, Mehring UM, Castaneda F, et al. Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Interv Radiol 1996;19:388-96.
33. Berger D, Carrasco C, Hohn D, Curley S. Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: Post-treatment management and complications. J Surg Oncol 1995;60:116-21.
34. Selby R, Kadry Z, Carr B, Tzakis A, Madariaga J, Iwatsuki S. Liver transplantation for hepatocellular carcinoma. World J Surg 1995;19:53-8.
35. Van Thiel D, Carr B, Iwatsuki S, Selby R, Fung J, Starzl T. The 11-year Pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981-1991. J Surg Oncol Suppl 1993;3:78-82.
36. Superina R, Bilik R. Results of liver transplantation in children with unresectable liver tumors. J Pediatr Surg 1996;31:835-9.
37. Pichlmayer R. Liver transplantation in primary hepatocellular carcinoma. J Hepatol 1993;18:151-3.
38. Tagge E, Tagge D, Reyes J, et al. Resection, including transplantation for hepatoblastoma and hepatocellular carcinoma: Impact on survival. J Pediatr Surg 1992;27:292-6.
39. Achilleos O, Buist L, Kelly D, et al. Unresectable hepatic tumors in childhood and the role of liver transplantation. J Pediatr Surg 1996;31:1563-7.
40. Reyes J, Carr B, Dvorchik I, et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence (submitted).